BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37661406)

  • 41. Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex.
    Chu YY; Chen MK; Wei Y; Lee HH; Xia W; Wang YN; Yam C; Hsu JL; Wang HL; Chang WC; Yamaguchi H; Jiang Z; Liu C; Li CF; Nie L; Chan LC; Gao Y; Wang SC; Liu J; Westin SN; Lee S; Sood AK; Yang L; Hortobagyi GN; Yu D; Hung MC
    Nat Cancer; 2022 Oct; 3(10):1211-1227. PubMed ID: 36253486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP.
    Ju W; Zhang M; Jiang JK; Thomas CJ; Oh U; Bryant BR; Chen J; Sato N; Tagaya Y; Morris JC; Janik JE; Jacobson S; Waldmann TA
    Blood; 2011 Feb; 117(6):1938-46. PubMed ID: 21106989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heat shock factor 1 is a promising therapeutic target against adult T-cell leukemia.
    Ishikawa C; Mori N
    Med Oncol; 2023 May; 40(6):172. PubMed ID: 37165174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The CDK9 tail determines the reaction pathway of positive transcription elongation factor b.
    Baumli S; Hole AJ; Wang LZ; Noble ME; Endicott JA
    Structure; 2012 Oct; 20(10):1788-95. PubMed ID: 22959624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Restoration of microRNA-212 causes a G0/G1 cell cycle arrest and apoptosis in adult T-cell leukemia/lymphoma cells by repressing CCND3 expression.
    Wang H; Guo Q; Yang P; Long G
    J Investig Med; 2017 Jan; 65(1):82-87. PubMed ID: 27493231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. G-actin participates in RNA polymerase II-dependent transcription elongation by recruiting positive transcription elongation factor b (P-TEFb).
    Qi T; Tang W; Wang L; Zhai L; Guo L; Zeng X
    J Biol Chem; 2011 Apr; 286(17):15171-81. PubMed ID: 21378166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1.
    Lemke J; von Karstedt S; Abd El Hay M; Conti A; Arce F; Montinaro A; Papenfuss K; El-Bahrawy MA; Walczak H
    Cell Death Differ; 2014 Mar; 21(3):491-502. PubMed ID: 24362439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-adult T‑cell leukemia/lymphoma activity of cerdulatinib, a dual SYK/JAK kinase inhibitor.
    Ishikawa C; Senba M; Mori N
    Int J Oncol; 2018 Oct; 53(4):1681-1690. PubMed ID: 30066853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination of 9-aminoacridine with Campath-1H provides effective therapy for a murine model of adult T-cell leukemia.
    Ju W; Zhang M; Petrus M; Maeda M; Pise-Masison CA; Waldmann TA
    Retrovirology; 2014 Jun; 11():43. PubMed ID: 24890041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
    Mori N; Matsuda T; Tadano M; Kinjo T; Yamada Y; Tsukasaki K; Ikeda S; Yamasaki Y; Tanaka Y; Ohta T; Iwamasa T; Tomonaga M; Yamamoto N
    J Virol; 2004 May; 78(9):4582-90. PubMed ID: 15078940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer.
    Frame S; Saladino C; MacKay C; Atrash B; Sheldrake P; McDonald E; Clarke PA; Workman P; Blake D; Zheleva D
    PLoS One; 2020; 15(7):e0234103. PubMed ID: 32645016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia.
    Watanabe M; Ohsugi T; Shoda M; Ishida T; Aizawa S; Maruyama-Nagai M; Utsunomiya A; Koga S; Yamada Y; Kamihira S; Okayama A; Kikuchi H; Uozumi K; Yamaguchi K; Higashihara M; Umezawa K; Watanabe T; Horie R
    Blood; 2005 Oct; 106(7):2462-71. PubMed ID: 15956280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia.
    Sher S; Whipp E; Walker J; Zhang P; Beaver L; Williams K; Orwick S; Ravikrishnan J; Walker B; Perry E; Gregory C; Purcell M; Pan A; Yan P; Alinari L; Johnson AJ; Frigault MM; Greer JM; Hamdy A; Izumi R; Mo X; Sampath D; Woyach J; Blachly J; Byrd JC; Lapalombella R
    Leukemia; 2023 Feb; 37(2):326-338. PubMed ID: 36376377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of P-TEFb elongation complex activity by CDK9 acetylation.
    Fu J; Yoon HG; Qin J; Wong J
    Mol Cell Biol; 2007 Jul; 27(13):4641-51. PubMed ID: 17452463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The small molecule STF-62247 induces apoptotic and autophagic cell death in leukemic cells.
    Kozako T; Sato K; Uchida Y; Kato N; Aikawa A; Ogata K; Kamimura H; Uemura H; Yoshimitsu M; Ishitsuka K; Higaki Y; Tanaka H; Honda SI; Soeda S
    Oncotarget; 2018 Jun; 9(45):27645-27655. PubMed ID: 29963226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate.
    Ramanathan Y; Reza SM; Young TM; Mathews MB; Pe'ery T
    J Virol; 1999 Jul; 73(7):5448-58. PubMed ID: 10364292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting cyclin-dependent kinase 9 sensitizes medulloblastoma cells to chemotherapy.
    Song H; Bhakat R; Kling MJ; Coulter DW; Chaturvedi NK; Ray S; Joshi SS
    Biochem Biophys Res Commun; 2019 Dec; 520(2):250-256. PubMed ID: 31594641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.
    Dewan MZ; Terashima K; Taruishi M; Hasegawa H; Ito M; Tanaka Y; Mori N; Sata T; Koyanagi Y; Maeda M; Kubuki Y; Okayama A; Fujii M; Yamamoto N
    J Virol; 2003 May; 77(9):5286-94. PubMed ID: 12692230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.